Drug Discovery World

NOVEMBER 21, 2023

Initial investments in 2024 The business will be seeking to make its first investments during 2024.

Development 52

Development Clinical Development Production Business Development 52

The Pharma Data

NOVEMBER 23, 2020

Berkien will join Ultimovacs from his current position at Amgen as Director Global Business Development. At Ultimovacs, he will lead all business and corporate development efforts and continue to maintain and foster connections with leading biotechnology and pharmaceutical companies. “In

Business Development 52

Business Development Clinical Trials Clinical Trials Licensing 52

pharmaphorum

NOVEMBER 17, 2020

How the NIHR’s Patient Engagement in Clinical Development service can help. Gareth Powell is a business development officer for the NIHR Clinical Research Network (CRN). Gareth has been with the Clinical Research Network since 2009. Gaining patient input on marketing and recruitment materials.

Clinical Trials 116

Clinical Trials Clinical Trials Trials Life Science 116

pharmaphorum

JANUARY 14, 2022

Fern invested in automation and expanded service offerings in both the lab and clinic, positioning the company for future growth. was senior vice president of business development, expanding the sales team and establishing key partnerships to meet the needs of sponsors. Before taking on the role as general manager, Fern?was

Clinical Trials 98

Clinical Trials Clinical Trials Trials Compliance 98

The Pharma Data

JANUARY 7, 2021

Seven product or product candidates discovered using APXiMAB are currently commercially available or in clinical development, either internally by Apexigen or by its licensees. Apexigen Contact: Mark Nevins Vice President, Business Development Apexigen 650-931-6236 mnevins@apexigen.com.

Antibody 40

Antibody Business Development Clinical Development Production 40

Drug Discovery World

FEBRUARY 12, 2024

In 2024, we can expect another wave of innovative new drugs to be developed using the technology, given that the AI-fuelled small molecule discovery pipeline is growing by almost 40% annually.”

Genome 139

Genome Genomics Life Science Gene Therapy 139

Drug Discovery World

JUNE 29, 2023

Kate Woolland, Chief Operating Officer, Closed Loop Medicine Bringing extensive strategic business experience, including over 13 years in healthcare, Kate will play a pivotal role in leading collaboration across the multi-disciplinary team whilst working closely with current and future commercial partners.

Drugs 52

Drugs Gene Therapy Development Clinical Trials 52

pharmaphorum

SEPTEMBER 18, 2020

All eyes may be on Moderna’s COVID-19 vaccine at the moment, but the US biotech hasn’t been idle in business development elsewhere, signing back-to-back deals with Vertex and Chiesi that have brought in $100 million upfront. .

Gene Editing 105

Gene Editing Gene Vaccination Vaccine 105

The Pharma Data

DECEMBER 3, 2020

Barnett joined Array in 2000, two years after the company was founded, and played an invaluable role in successfully bringing Mektovi and Braftovi, two precision oncology medicines, to market while serving in a range of roles including research, business development and technical operations. Liquidia Corporation – N.C. Source link.

Development 52

Development Business Development Manufacturing Clinical Development 52

The Pharma Data

JUNE 7, 2023

Acuitas’ proprietary LNP technology is used in multiple vaccines and therapeutics in clinical development and was also used in some of the COVID-19 vaccines that were approved and administered to people in 180 countries. LNPs are spheric drug delivery bodies which can be equipped with therapeutic payloads for intracellular delivery.

Gene Therapy 40

Gene Therapy Gene Gene Editing RNA 40

pharmaphorum

OCTOBER 13, 2022

His most recent position in R&D included responsibility for finance, pipeline resource planning and allocation, business development deal structuring and SROne (GSK’s in-house $125m venture capital fund). He also chaired GSK’s R&D Operating Board. Prior to GSK, he worked at Unilever.

Vaccination 52

Vaccination Vaccine Life Science Development 52

The Pharma Data

OCTOBER 14, 2020

APX005M is currently in Phase 2 clinical development for the treatment of cancers such as pancreatic cancer, esophageal and gastroesophageal junction cancers, melanoma, non-small cell lung cancer, rectal cancer and sarcoma in various combinations with immunotherapy, chemotherapy, radiation therapy or a cancer vaccine.

Immune Response 40

Immune Response Drugs Antibody Clinical Trials 40

The Pharma Data

NOVEMBER 10, 2020

Growing into a biopharmaceutical company, Innovent has built an integrated platform covering from drug discovery, CMC, clinical development and commercialization. By joining Innovent, Dr. Liu will be responsible for global R & D, pipeline strategy, business development and international operations.

Clinical Trials 52

Clinical Trials Clinical Trials Manufacturing Production 52

Drug Discovery World

JUNE 16, 2023

This experience also involves technology transfers, for therapies across the clinical development stages and for developers based across global regions, from the US, through Europe and to China. This experience has resulted in very low batch failure rates, which has a considerable reduction in the cost of production.

Manufacturing 52

Manufacturing In-Vivo Production Compliance 52

The Pharma Data

SEPTEMBER 15, 2020

The results of her research were published in a number of articles highlighting her knowledge of the critical challenges of clinical sites and of the importance of being patient-centric. She began her career at S-Clinical as a business developer and progressed to be the Head of Operations. 7am PDT.

Clinical Supply 52

Clinical Supply Clinical Supply Chain Doctors Doctor 52

Drug Discovery World

JUNE 15, 2023

However, we need to avoid unnecessary delays in clinical development, and interactions between EU countries and with US regulators need to be homogenised if we want to interact with EU and US regulators.” BioSenic’s had 44 centres open in Europe for the latest Phase IIb clinical trial for difficult tibia fractures, which is just finishing.

Regulation 52

Regulation Production Development Medicine 52

The Pharma Data

NOVEMBER 9, 2020

IP-001 is the first of what is expected to be many novel agents and combinations that we bring into clinical development to help patients suffering from cancer.”. Contact: Dr. Theresa Visarius Vice President Business Development, Immunophotonics, Inc. Markus Jörger, M.D., The company is based in St.

Immune Response 40

Immune Response Clinical Trials Clinical Trials Trials 40

pharmaphorum

SEPTEMBER 21, 2021

As these promising therapies move into clinical development, we need to ensure qualified patients are diagnosed, identified and engaged early on in drug development and aware of these trials so that these innovations have the best possible chance to make it to patients.

Gene Therapy 90

Gene Therapy Gene Clinical Trials Clinical Trials 90

The Pharma Data

JANUARY 12, 2021

Marianne De Backer, Head of Business Development & Licensing in Bayer’s Pharmaceuticals Division, pictured above. Each of the companies met strict criteria that includes assets in clinical development, an industry-leading platform and in-house manufacturing capabilities. “We Photo courtesy of Bayer.

Gene Therapy 52

Gene Therapy Gene Gene Editing Licensing 52

The Pharma Data

JANUARY 12, 2021

Dr Graham is a medicines development expert and Infectious Diseases Epidemiologist with global Biotech and Pharma R&D experience in Phase I-IV therapeutics as well as in-vivo & in-vitro diagnostics, across many modalities. He has in depth Global Development Expertise (e.g.

Life Science 52

Life Science Antibody In-Vivo In-Vitro 52

The Pharma Data

DECEMBER 17, 2020

Cadavid will be responsible for the strategy, direction and execution of the company’s clinical development programs. Prior to Fulcrum, Cadavid held several leadership positions at Biogen, including Senior Medical Director of the multiple sclerosis clinical development group.

Development 52

Development Gene Therapy Engineer Life Science 52

The Pharma Data

JANUARY 24, 2021

Given that we have already treated patients with StemVacs, and we have filed an Investigational New Drug (IND) application for this product, we are excited in its development prospects.” ” “Immunotherapy has been a priority of our company from the beginning.

Marketing 52

Marketing Development Business Development Drugs 52

pharmaphorum

MARCH 8, 2022

After a few years, I decided I wanted to move into the commercial side of the business, so I completed an MBA and went on to hold various positions in Corporate Business Development, Life Science and Healthcare. Avideh Nazeri is vice president clinical development, medical, and regulatory affairs, Novo Nordisk UK.

Life Science 98

Life Science Engineer Scientist Doctors 98

The Pharma Data

NOVEMBER 3, 2020

According to the FDA, the purpose of Fast Track designation is to get important new drugs to patients earlier by facilitating the development, and expediting the review, of drugs to treat serious conditions and fill an unmet medical need. Commenting on the announcement, Daniel Gruskin, M.D., LogicBio is headquartered in Lexington, Mass.

Clinical Trials 52

Clinical Trials Clinical Trials Gene Editing Genome 52

Pharmaceutical Technology

DECEMBER 22, 2022

The funding will offer capital to extend Blueprint’s varied pipeline toward marketing as well as to continue seeking strategic and synergistic business development prospects. Be Bio Blueprint Medicines Endeavor BioMedicines Kallyope Metagenomi Mineralys Neuron23 Nutcracker RayzeBio Rivus Ventus Therapeutics. Innovation.

Insulin 130

Insulin Production Development Genetics 130

Drug Discovery World

AUGUST 28, 2023

He is a recognised leader in drug discovery, having spent 15 years at Sanofi, most recently as Global Head of External Innovation, Drug Discovery in Business Development. LinkedIn profile.

Genetics 52

Genetics Protein Genetic Disease Clinical Trials 52

The Pharma Data

APRIL 6, 2022

Novartis will create a new Strategy & Growth function combining corporate strategy, R&D portfolio strategy and business development. Aradhye has dedicated his entire professional career to improving patient lives, first as an academic clinician and then as a drug developer and business leader.

Medicine 52

Medicine Sales Development Marketing 52

Drug Discovery World

JUNE 5, 2023

New approaches to partnering In this event in the Biotech track, Clive Cookson, Science Editor at the Financial Times, interviewed John McDonald, Corporate Vice President, Global R&D Business Development, Novo Nordisk. The discussion answered three main questions: What is the new direction for the company?

Genome 52

Genome Genomics Life Science Genetics 52

The Pharma Data

JANUARY 21, 2021

Prior to her 11-year tenure at Medtronic, Humphrey served as an associate principal at McKinsey & Company, advising corporate clients on growth, commercial, operational and business development strategies. Talking Medicines – Social medicines company Talking Medicines tapped three senior executives. and Genentech, Inc.

Medicine 52

Medicine Development Engineer Production 52

The Pharma Data

JUNE 28, 2021

“Despite increased cancer survivorship overall, there continues to be significant unmet need in oncology,” said Marianne De Backer, MBA, PhD, Member of the Executive Committee of the Pharmaceuticals Division and Head Strategy and Business Development & Licensing at Bayer. “We

Licensing 52

Licensing Licensing Medicine Development 52

Drug Discovery World

MAY 16, 2023

According to Foster, the industry needs to work together to address the problems from the earliest phases of pre-clinical development. Clinical endpoints are no longer the only things that matter. Allogeneic cell therapy is also starting to accelerate in early development programs. The solution?

Gene Therapy 52

Gene Therapy Gene Manufacturing Marketing 52

pharmaphorum

FEBRUARY 11, 2021

Participants agreed that the best approach is to engage with patients early in the clinical development process, preferably before protocols are finalised, in order to maximise benefits from their input and allow the clinical trial process to run smoothly. “We Linking pharma with patients.

Clinical Trials 101

Clinical Trials Clinical Trials Trials Clinical Research 101

The Pharma Data

NOVEMBER 5, 2020

Taveras will lead all research and non-clinical development functions supporting the company’s pipeline of investigational therapies. VectivBio AG – Based in Switzerland, VectivBio named Sarah Holland as chief business officer and Aditya Venugopal as head of business development.

Genome 40

Genome Genomics Medicine Life Science 40

The Pharma Data

DECEMBER 8, 2020

Now poised to advance a robust therapeutics pipeline to clinical development, Nuance will use the funds for ongoing R&D of existing products and business development of potential new assets. Sigilon Therapeutics . Now live on the ticker, Sigilon hopes to sell 7 million shares for a $126 million raise.

RNA 52

RNA Antibody Life Science Protein 52

pharmaphorum

NOVEMBER 15, 2022

Joining her onstage were Dominique Bridon CEO of Diaccurate, Matthias Müllenbeck SVP, head global business development & alliance management Merck KGaA, and Catherine Pickering CEO iOnctura. But he noted getting the right people on the right path to success allows companies to create a more impactful story to put to investors.

Life Science 96

Life Science Pharma Companies Marketing Production 96

The Pharma Data

JANUARY 4, 2021

Barber’s work will give Kiromic a significant acceleration in the clinical development of its therapy platform and an even more significant advantage over its competitors. Amorette Barber of Longwood University will be heading up our chPD1 program. “We believe Prof.

In-Vivo 40

In-Vivo Development Immune Response Big Data 40

The Pharma Data

JANUARY 17, 2021

The companies announced in January 2019 a collaboration agreement to develop, manufacture and commercialize SPR206 in the Territory. SPR206 is in clinical development as an innovative option for the treatment of multi-drug resistant (MDR) Gram-negative bacterial infections. SHANGHAI , Jan.

Medicine 52

Medicine Clinical Development Clinical Trials Clinical Trials 52